ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • J Alzheimers Dis Parkinsonism 2018, Vol 8(5): 450
  • DOI: 10.4172/2161-0460.1000450

Reversal of Cognitive Decline: 100 Patients

Ann Hathaway8, Mary Braud16, Patricia Henry16, Ilene Naomi Rusk16, Jean Lawrence15, Carol Diamond14, Nathaniel Bergman13, Amylee Amos12, Edwin Amos11, David Hagedorn10, Mikhail Kogan9, Dale E Bredesen1*, Craig Tanio7, Seth Conger6, Ronald L Brown6, Anne Stefani5, Sharon Hausman Cohen5, Wes Youngberg4, Miki Okuno3, David Jenkins3 and Kenneth Sharlin2
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
2Sharlin Health and Neurology/Functional Medicine, Ozark, MO, USA
3NeuroHub, Sydney, Australia
4Youngberg Lifestyle Medicine Clinic, Temecula, CA, USA
5Resilient Health, Austin, TX, USA
6Carolina Healthspan Institute, Charlotte, NC, USA
7Rezilir Health, Hollywood, FL, USA
8Integrative Functional Medicine, San Rafael, CA, USA
9GW Center for Integrative Medicine, George Washington University, Washington, DC, USA
10Coastal Integrative Medicine, Jacksonville, NC, USA
11Department of Neurology, University of California, Los Angeles, Los Angeles, CA, USA
12Amos Institute, Los Angeles, CA, USA
13Center for Functional Medicine, Cleveland Clinic, Cleveland, OH, USA
14Mount Sinai Hospital, New York, NY, USA
15Lawrence Health and Wellness, Toccoa, GA, USA
16Brain and Behavior Clinic, Boulder, CO, USA
*Corresponding Author : Dale E Bredesen, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA, Tel: +014152541041, Email: dbredesen@buckinstitute.org

Received Date: Oct 08, 2018 / Accepted Date: Oct 12, 2018 / Published Date: Oct 19, 2018

Keywords: Alzheimer’s; Mild cognitive impairment; Programmatics; ReCODE; Precision medicine; Amyloid precursor protein; Synaptoblastic; Synaptoclastic

Citation: Bredesen DE, Sharlin K, Jenkins D, Okuno M, Youngberg W, et al. (2018) Reversal of Cognitive Decline: 100 Patients. J Alzheimers Dis Parkinsonism 8: 450. Doi: 10.4172/2161-0460.1000450

Copyright: © 2018 Bredesen DE, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top